These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11083108)

  • 41. Breaching the skin's barrier to drugs.
    Barry BW
    Nat Biotechnol; 2004 Feb; 22(2):165-7. PubMed ID: 14755286
    [No Abstract]   [Full Text] [Related]  

  • 42. In vitro dermal disposition of abamectin (avermectin B(1)) in livestock.
    Baynes RE
    Res Vet Sci; 2004 Jun; 76(3):235-42. PubMed ID: 15046958
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Study on dermal absorption of Imidacloprid in vitro].
    Li CX; Li M; Feng XL; Cao P; Wang XD; Liu S; Xu HB
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2012 Aug; 30(8):604-7. PubMed ID: 22931882
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Skin decontamination: Importance of the wash-in effect.
    Moody RP; Maibach HI
    Food Chem Toxicol; 2006 Nov; 44(11):1783-8. PubMed ID: 16872731
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Skin absorption of actinides: influence of solvents or chelates on skin penetration ex vivo.
    Tazrart A; Bolzinger MA; Coudert S; Lamart S; Miller BW; Angulo JF; Briançon S; Griffiths NM
    Int J Radiat Biol; 2017 Jun; 93(6):607-616. PubMed ID: 28276896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Advances in the bioanalytical study of drug delivery across the skin.
    Depieri LV; Praça FS; Campos PM; Bentley MV
    Ther Deliv; 2015; 6(5):571-94. PubMed ID: 26001174
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of equine skin preparation on transdermal drug penetration in vitro.
    Mills PC; Cross SE
    Can J Vet Res; 2006 Oct; 70(4):317-20. PubMed ID: 17042388
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro Dermal Absorption: Sample Application and Seal Quality in a Franz Diffusion Cell System.
    Desmedt B; Courselle P; De Beer JO; Rogiers V; Deconinck E; De Paepe K
    Skin Pharmacol Physiol; 2015; 28(5):245-9. PubMed ID: 25765467
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Two-dimensional transport analysis of transdermal drug absorption with a non-perfect sink boundary condition at the skin-capillary interface.
    Simon L; Ospina J
    Math Biosci; 2013 Jul; 244(1):58-67. PubMed ID: 23624255
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A two-dimensional mathematical model of non-linear dual-sorption of percutaneous drug absorption.
    George K
    Biomed Eng Online; 2005 Jul; 4():40. PubMed ID: 15992411
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Percutaneous absorption: physical chemistry meets the skin.
    Guy RH
    Curr Probl Dermatol; 1995; 22():132-8. PubMed ID: 7587314
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of low-frequency ultrasound on the transdermal permeation of mannitol: comparative studies with in vivo and in vitro skin.
    Tang H; Blankschtein D; Langer R
    J Pharm Sci; 2002 Aug; 91(8):1776-94. PubMed ID: 12115805
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Finite dose percutaneous drug absorption: a BASIC program for the solution of the diffusion equation.
    Kubota K
    Comput Biomed Res; 1991 Apr; 24(2):196-207. PubMed ID: 1903685
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A physiologically based mathematical model of dermal absorption in man.
    Auton TR; Westhead DR; Woollen BH; Scott RC; Wilks MF
    Hum Exp Toxicol; 1994 Jan; 13(1):51-60. PubMed ID: 8198830
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surfactant effects on skin absorption of model organic chemicals: implications for dermal risk assessment studies.
    Riviere JE; Brooks JD; Yeatts JL; Koivisto EL
    J Toxicol Environ Health A; 2010; 73(11):725-37. PubMed ID: 20391115
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of ciclopirox olamine topical formulations: evaluation of drug release, penetration and cutaneous retention.
    Pinheiro VA; Serikaku D; Baby AR; Velasco MV; Kaneko TM; Consiglieri VO
    Pharm Dev Technol; 2015 Mar; 20(2):197-203. PubMed ID: 24286179
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A simplified approach for estimating skin permeation parameters from in vitro finite dose absorption studies.
    Lehman PA
    J Pharm Sci; 2014 Dec; 103(12):4048-4057. PubMed ID: 25324199
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Percutaneous absorption of 2,4-dichlorophenoxyacetic acid from soil with respect to soil load and skin contact time: in vivo absorption in rhesus monkey and in vitro absorption in human skin.
    Wester RC; Melendres J; Logan F; Hui X; Maiback HI; Wade M; Huang KC
    J Toxicol Environ Health; 1996 Mar; 47(4):335-44. PubMed ID: 8600287
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fluorescence evaluations for porphyrin formation during topical PDT using ALA and methyl-ALA mixtures in pig skin models.
    Fujita AK; Rodrigues PG; Requena MB; Escobar A; da Rocha RW; Nardi AB; Kurachi C; de Menezes PF; Bagnato VS
    Photodiagnosis Photodyn Ther; 2016 Sep; 15():236-44. PubMed ID: 27288253
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Percutaneous absorption of benzo[a]pyrene in the rat: comparison of in vivo and in vitro results.
    Yang JJ; Roy TA; Mackerer CR
    Toxicol Ind Health; 1986 Dec; 2(4):409-16. PubMed ID: 3590196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.